Current Time Inside Cache Tag Helper: 9/25/2021 10:15:15 PM and Model.SegmentId = 365

Drug Diversion Monitoring  

Subject Expert

Jackson Tate

Research Director

jackson.tate@klasresearch.com

801-734-6503

KLAS Research Director - Jackson Tate

Preferences

   Bookmark

Related Blogs




Current Time Inside Cache Tag Helper: 9/25/2021 6:31:58 PM and Model.SegmentId = 365
Related Reports View All Reports



Exceptions

R
Regional Classification
C
Component Products
S
Superseded Products
NP
Not Primary Products
DR
Data Review
MS
Limited Market Share
E
Emerging Technology
FR
Data frozen, live data no longer collected.

The following exceptions refer to the number of unique organizations contributing evaluations to the overall score (minimum of 15 required).

Drug Diversion Monitoring

# of Unique Organization Evaluations:

0 - 5
L
6 - 14

Reducing Filters

Unlike sizing filters, reducing filters DO NOT recalculate scores based on the evaluations that meet these requirements. They narrow the list of solutions to show the vendors and solutions that can meet a specific need.

This data is based on interviews with a sample of the firms' recent clients. As a result, it is not necessarily comprehensive of all work a firm may do in this segment.

We require a minimum of 2 confirmations of a service performed in the last 3 years for a solution to qualify.

Market Energy

This is an indication of the relative considerations of Market Energy within the shown products from the

Decision Insights KLAS Data

Market Energy Levels:

Low Market Energy
Medium Market Energy
High Market Energy
Not Enough Data